We present three small biotech stocks, which according to Wall Street analysts, have upside potential for 2025.

Bird flu has emerged as a critical public health concern in California, with Governor Gavin Newsom declaring a state of ...

Let's explore two healthcare sector dividend stocks that could make a fantastic addition to your ... Pfizer has struggled in ...

Moderna 's ( MRNA 3.13%) wild success in the COVID-19 vaccine market has worn off. The company's revenue, earnings, and stock ...

After falling off their perch in the last few months of 2024, European healthcare stocks head into a new year facing the ...

Argus downgraded Moderna (MRNA) to Hold from Buy without a price target The firm sees limited upside for the stock over the next 12 months as ...

Investing in biotech stocks usually isn't for the faint of heart. These stocks tend to be highly volatile because of the ...

As flu season chugs along, cases of Whooping Cough are on the rise. According to the Eau Claire City-County Health Department, the county has reported 26 cases. That is a stark rise from last year ...

Pfizer shares rallied after the drugmaker's 2025 guidance met Wall Street expectations, cheering shareholders as the company faces pressure to improve performance. The company forecast next year’s ...

Pfizer ( SOY-T -1.26% ) on Tuesday forecast 2025 profits roughly in line with Wall Street expectations, offering some relief ...

BioVaxys Technology (TSE:BIOV) has released an update.Pick the best stocks and maximize your portfolio:Discover top-rated stocks from highly ...